High Opioid Costs in Argentina

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,

Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.

Molecular Biology of Opioid Analgesia

Palliative Sedation at Home for Terminally Ill Children With Cancer

Chronic Pain Management in Older Adults: Special Considerations

Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,

Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study David C. Currow, BMed, MPH, FRACP, Christine McDonald, MBBS, PhD,

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO

Steady-State Kinetics and Dynamics of Morphine in Cancer Patients

Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,

Chronic Pain Management in Older Adults: Special Considerations

Possible exacerbation of adrenal suppression from intrathecal morphine in a patient receiving pulsed dexamethasone for multiple myeloma Arun Rajagopal,

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

Use of Transcutaneous Electrical Nerve Stimulation in a Young Child with Pain from Open Perineal Lesions Sandra I Merkel, MS, RN, Howard B Gutstein,

Pain Medication During Terminal Care of Children with Cancer

Interactive Collaborative Consultation Model in End-Of-Life Care

Optimization of opioid therapy for preventing incident pain associated with bone metastases Sebastiano Mercadante, MD, Patrizia Villari, MD, Patrizia.

Pain, Fatigue, and Sleep Disturbances in Oncology Outpatients Receiving Radiation Therapy for Bone Metastasis Christine Miaskowski, RN, PhD, FAAN, Kathryn.

Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine Rainer Sabatowski, MD, Stefan.

The adequacy of the minimum data set assessment of pain in cognitively impaired nursing home residents Jiska Cohen-Mansfield, PhD, ABPP Journal of Pain.

Cross-Sectional Pilot Study to Monitor the Availability, Dispensed Prices, and Affordability of Opioids Around the Globe Liliana De Lima, MHA, Tania.

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

Samy A. Alsirafy, MBBCh, MSc, MD, ABHPM, Dip Pall Med

Arif H. Kamal, MD, David C. Currow, BMed, MPH, Christine S

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative.

David M. Dosa, MD, MPH, David D

The symptoms of dying children

Gastrointestinal Effects of NSAIDs and Coxibs

The Opioid Rotation Ratio From Transdermal Fentanyl to “Strong” Opioids in Patients With Cancer Pain Akhila Reddy, MD, Sriram Yennurajalingam, MD, MS,

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Kerala, India Journal of Pain and Symptom Management

Slovenia Journal of Pain and Symptom Management

Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

A Survey of Practice in Management of Malignant Ascites

Peak Plasma Concentrations After Oral Morphine

Abuse Potential of Morphine/Dextromethorphan Combinations

A Comparative Review of Palliative Care Development in Six Countries Represented by the Middle East Cancer Consortium (MECC) Amanda Bingley, PhD, David.

The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease Qutaiba A. Tawfic,

Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.

Cancer Pain Assessment and Management Recommendations by Hospice Nurses Paul A Sloan, MD, Barbara L Vanderveer, BSN, Janet S Snapp, BSN, Mitzi Johnson,

Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.

Antonio T. Fernando, MD, Nathan S. Consedine, PhD

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Improving Access to Opioid Analgesics for Palliative Care in India

Drug Infusors in Palliative Medicine

Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

Pain and Policy Studies Group: Two Decades of Working to Address Regulatory Barriers to Improve Opioid Availability and Accessibility Around the World

A Double-Blind, Randomized, Crossover Comparison Between Single-Dose and Double-Dose Immediate-Release Oral Morphine at Bedtime in Cancer Patients Ola.

Gabapentin and an Opioid Combination Versus Opioid Alone for the Management of Neuropathic Cancer Pain: A Randomized Open Trial Kader Keskinbora, MD,

A Preliminary Study of the Utility of the Brief Hospice Inventory

The Asia Pacific Hospice Palliative Care Network

A Titrated Morphine Analgesic Regimen Comparing Substance Users and Non-Users with AIDS-Related Pain Ronald Kaplan, MD, Joseph Slywka, PhD, Susan Slagle,

Physical Function in Patients with Cancer

Spain Journal of Pain and Symptom Management

Nathaniel P Katz, MD Journal of Pain and Symptom Management

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine.

Molecular Biology of Opioid Analgesia

Longitudinal Documentation of Cancer Pain Management Outcomes

Amy P. Abernethy, MD Journal of Pain and Symptom Management

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

The bioavailability of morphine applied topically to cutaneous ulcers

How Should End-of-Life Advance Care Planning Discussions Be Implemented According to Patients and Informal Carers? A Qualitative Review of Reviews Alex.

Patient-Controlled Analgesia for Children at Home

Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno,

Opioid Equianalgesic Tables: Are They All Equally Dangerous?

Presentation transcript:

High Opioid Costs in Argentina Roberto Wenk, MD, Mariela Bertolino, MD, Juan Pussetto, MD Journal of Pain and Symptom Management Volume 20, Issue 2, Pages 81-82 (August 2000) DOI: 10.1016/S0885-3924(00)00187-1

Fig. 1 Cost evolution of morphine. Daily dose = 180 mg. 1 US$ =1$. SR, sustained release; IR, immediate release. Magistral morphine: mean value (US$155); standard deviation 52, min. 65, max. 362. IR morphine #2: wholesale cost (>500 pills). Source: Manual Farmacéutico, Editorial AlfaBeta, ISSN 0329-06389 Journal of Pain and Symptom Management 2000 20, 81-82DOI: (10.1016/S0885-3924(00)00187-1)